KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Goodwill (2018 - 2025)

Adaptive Biotechnologies' Goodwill history spans 8 years, with the latest figure at $119.0 million for Q4 2025.

  • For Q4 2025, Goodwill changed 0.0% year-over-year to $119.0 million; the TTM value through Dec 2025 reached $119.0 million, changed 0.0%, while the annual FY2025 figure was $119.0 million, 0.0% changed from the prior year.
  • Goodwill for Q4 2025 was $119.0 million at Adaptive Biotechnologies, roughly flat from $119.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $119.0 million in Q1 2021 and bottomed at $119.0 million in Q1 2021.
  • The 5-year median for Goodwill is $119.0 million (2021), against an average of $119.0 million.
  • The largest YoY upside for Goodwill was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Goodwill shows it stood at $119.0 million in 2021, then changed by 0.0% to $119.0 million in 2022, then changed by 0.0% to $119.0 million in 2023, then changed by 0.0% to $119.0 million in 2024, then changed by 0.0% to $119.0 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Goodwill are $119.0 million (Q4 2025), $119.0 million (Q3 2025), and $119.0 million (Q2 2025).